Firefly Neuroscience
AIFF
19 hedge funds and large institutions have $1.69M invested in Firefly Neuroscience in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
182% more capital invested
Capital invested by funds: $597K → $1.69M (+$1.09M)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
58% more funds holding
Funds holding: 12 → 19 (+7)
2.66% more ownership
Funds ownership: 2.65% → 5.32% (+2.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$355K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$322K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$166K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$104K |
| 5 |
Morgan Stanley
New York
|
+$84.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$115K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$30K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$1.48K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.29K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5 |
AIFF Hedge Fund Activity: Q1 2025 in Review
19 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q1 2025, worth a combined $1.69M — up 182% from $597K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AIFF positions and 2 closed out — a net gain of 7 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $355K. The largest seller was Millennium Management, exiting entirely with an estimated $115K sold.
- 19 institutional investors held Firefly Neuroscience (AIFF) as of Q1 2025, up from 12 in Q4 2024.
- Funds reported $1.69M of Firefly Neuroscience stock for Q1 2025, up 182% quarter-over-quarter.
- 9 funds opened new Firefly Neuroscience positions in Q1 2025 and 2 closed out, a net change of +7 holders.
- The largest Firefly Neuroscience buyer in Q1 2025 was UBS Group, an estimated $355K added.
- The largest Firefly Neuroscience seller in Q1 2025 was Millennium Management, an estimated $115K sold.
Based on aggregated 13F filings for Q1 2025.